Great Point Partners’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Great Point Partners's CCXI Position: Q4 2020 in Review
Great Point Partners sold out of ChemoCentryx (CCXI) in Q4 2020, closing a stake of 253,230 shares — an estimated $13.9M sold.
Great Point Partners first reported a position in CCXI in Q4 2013 and held it in 5 quarters. The position peaked at $14.4M in Q1 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.
- Great Point Partners reported no remaining ChemoCentryx position as of Q4 2020 after selling out during the quarter.
- Great Point Partners sold 253,230 ChemoCentryx shares in Q4 2020, an estimated $13.9M.
- Great Point Partners first reported a position in ChemoCentryx in Q4 2013 and held it in 5 quarters.
- Great Point Partners's ChemoCentryx position peaked at $14.4M in Q1 2020.
- 196 funds tracked by Wall St. Rank held ChemoCentryx as of Q4 2020.
Based on Great Point Partners's 13F filing for Q4 2020, filed 16 Feb 2021.